ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Journal and News Scan

Source: Journal of Thoracic and Cardiovascular Surgery
Author(s): Shinichi Fukuhara, MD, Minhaj S. Khaja, MD, MBA, David M. Williams, MD, Xhorlina Marko, MD, Bo Yang, MD, PhD, Himanshu J. Patel, MD, Karen M. Kim, MD, MSc
This paper shows that landing zone optimization using aortic septotomy resulted in a much higher positive aortic remodeling rate, whereas standalone TEVAR outcomes without adjunctive procedures for cTBAD were unfavorable. The authors show that routine aortic septotomy may have a positive effect on long-term cTBAD survival and expand TEVAR candidacy.
Source: Annals of Thoracic Surgery
Author(s): Alexander P. Nissen, Timothy J. Vreeland, Mediget Teshome, Michael A. Archer, Amanda B. Francescatti, Matthew H. G. Katz, Kelly K. Hunt, Linda Zheng, Timothy W. Mullett
The following editorial focuses on CoC Standard 5.8 for curative-intent resection of primary pulmonary malignancy. We offer a summary of Standard 5.8, and relevant data upon which it is based, in hopes of improving implementation in 2021 and improving compliance, which will first be assessed during site reviews taking place in 2022. We also describe best practices for pathologists, registrars and surgeons to achieve these compliance goals.
Source: European Journal of Cardio-Thoracic Surgery
Author(s): Bertrand Mennecier, Anne Olland, Céline Mascaux, Pierre-Emmanuel Falcoz
This invited commentary offers insights into a manuscript that provides a deeper understanding of the perioperative outcomes of patients with stage II/IV non-small-cell lung cancer (NSCLC) with tumour resection after neoadjuvant immunotherapy, alone or as part of multimodal treatment.
Source: Journal of Thoracic and Cardiovascular Surgery
Author(s): Christopher Wilcox, DO, Nikolhaus Smith, MD, Glenn J.R. Whitman, MD
It is difficult to identify patients with myocardial infarction after they have undergone heart surgery, but this manuscript presents a useful algorithm to help one decide between watchful waiting and immediate action.
Source: JTCVS
Author(s): Jarosław Bis, MD, Kinga Gościńska-Bis, MD, Krzysztof S. Gołba, MD, Radosław Gocoł, MD, Marcin Zębalski, MD, Marek A. Deja, MD, PhD
It is generally necessary to implant a permanent pacemaker (PPM) in 1% to 5% of patients undergoing cardiac surgery due to conduction disturbances. The authors of this study sought to discover whether PPM implantation timing and particular conduction disturbances are linked to the need for a permanent pacemaker. They concluded that implanting a PPM on postoperative day 7 was optimal for preventing unnecessary implantations and long-term hospitalizations.
Source: The Annals of Thoracic Surgery
Author(s): Tom C. Nguyen MD, Vinod H. Thourani MD, Alexander P. Nissen MD, Robert H. Habib PhD, Joseph A. Dearani MD, Allan Ropski MS

This is the largest analysis of COVID-19 related impact on adult cardiac surgery volume, trends, and outcomes. During the pandemic, cardiac surgery volume suffered dramatically, particularly in the Mid-Atlantic and New England regions during the first COVID-19 surge, with a concurrent increase in observed-to-expected 30-day mortality.

Source: The New England Journal of Medicine
Author(s): Peter Verhamme, B. Alexander Yi,Annelise Segers, Janeen Salter, Daniel Bloomfield, Harry R. Büller, Gary E. Raskob, Jeffrey I. Weitz

Interesting multi-center RCT that paves the way for potential paradigm shifts in antithrombotic modulation. The abcence of symptomatic pulmonary embolism warrants further investigation...

Source: Interactive CardioVascular and Thoracic Surgery
Author(s): Marcus Taylor, Glen P Martin, Udo Abah, Matthew Sperrin, Matthew Smith, Dilraj Bhullar, Michael Shackcloth, Steve Woolley, Doug West, Rajesh Shah, Stuart W Grant
This study used data from 6600 lung resections performed in the UK between 2012 and 2018 to develop a prediction model for 90-day mortality after lung resection.
Source: European Journal of Cardio-Thoracic Surgery
Author(s): Konstantinos Tsagakis, Anja Osswald, Alexander Weymann, Aydin Demircioglu, Bastian Schmack, Daniel Wendt, Heinz Jakob, Arjang Ruhparwar
This study focused on FET proximalization used in combination with four-sites perfusion and results show that these techniques when performed together have the potential to improve patient outcomes in terms of survival and major events.
Source: JAMA Surgery
Author(s): H Yang, H Liu, Y Chen, et al

Although the standard of care in the West for regionally advanced esophageal cancer entails induction therapy, this is routinely not the case in China. This randomized trial involving over 450 randomized participants to induction therapy (vinorelbine, cisplatin, 40 Gy RT) followed by resection vs resection alone. At a median f/u of 53.5 mos, trimodality therapy demonstrated overall (HR 0.74; CI 0.57-0.97) and disease free (HR 0.60; CI 0.45 to 0.80) survival advantages compared to surgery alone. This study may establish a new standard of care for management of resectable regionally advanced esophageal cancer in China.

Pages